By Tarun Sai Lomte An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing ...

Changes in purchasing patterns after glucagon-like peptide-1 receptor agonist (GLP-1RA) initiation were seen across most nutrient ...

Key market opportunities for GLP-1 analogues include growth in the oral administration segment, expanding presence in Asia-Pacific and emerging markets, and strategic partnerships. Regulatory ...

Drugs like Ozempic already have a big impact on how much patients eat - and now they may be changing the way they shop and ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

By Vijay Kumar Malesu New trial evidence shows that without structured exercise, weight loss medications may leave physical ...

Grocery industry organisation IGD (the Institute of Grocery Distribution) has launched an insight programme focused on GLP-1 ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.

A 6-month tailored weight loss program helps US veterans with serious mental illness achieve significant weight reduction.

The GLP-1 tirzepatide is only one half of the puzzle.

Researchers conducted a cohort study to assess the effect of incretin receptor agonist therapy on continuous positive airway pressure use in T2D, obesity, and OSA.